Literature DB >> 26372820

Inflammation, Immunity, and Vaccines for Helicobacter pylori Infection.

Anna Walduck1, Leif P Andersen2, Sukanya Raghavan3.   

Abstract

During the last year, a variety of studies have been published that increases our understanding of the basic mechanisms of immunity and inflammation in Helicobacter pylori infection and progression to gastric cancer. Innate immune regulation and epithelial cell response were covered by several studies that contribute with new insights in the host response to H. pylori infection. Also, the adaptive immune response to H. pylori and particularly the role of IL-22 have been addressed in some studies. These advances may improve vaccine development where new strategies have been published. Two major studies analyzed H. pylori genomes of 39 worldwide strains and looked at the protein profiles. In addition, multi-epitope vaccines for therapeutic use have been investigated. Studies on different adjuvants and delivery systems have also given us new insights. This review presents articles from the last year that reveal detailed insight into immunity and regulation of inflammation, the contribution of immune cells to the development of gastric cancer, and understanding mechanisms of vaccine-induced protection.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Helicobacter pylori; IL-23 and vaccines; inflammation

Mesh:

Substances:

Year:  2015        PMID: 26372820     DOI: 10.1111/hel.12252

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

Review 1.  Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation.

Authors:  Sulaimon Idowu; Paul P Bertrand; Anna K Walduck
Journal:  Helicobacter       Date:  2022-04-05       Impact factor: 5.182

2.  Helicobacter pylori infection downregulates duodenal CFTR and SLC26A6 expressions through TGFβ signaling pathway.

Authors:  Guorong Wen; Shili Deng; Wenfeng Song; Hai Jin; Jingyu Xu; Xuemei Liu; Rui Xie; Penghong Song; Biguang Tuo
Journal:  BMC Microbiol       Date:  2018-08-17       Impact factor: 3.605

3.  Status of vaccine research and development for Helicobacter pylori.

Authors:  Philip Sutton; Joanne M Boag
Journal:  Vaccine       Date:  2018-04-05       Impact factor: 3.641

4.  Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection.

Authors:  Zifan Song; Biaoxian Li; Yingxuan Zhang; Ruizhen Li; Huan Ruan; Jing Wu; Qiong Liu
Journal:  Front Microbiol       Date:  2020-06-23       Impact factor: 5.640

5.  The Exopolysaccharide of Lactobacillus fermentum UCO-979C Is Partially Involved in Its Immunomodulatory Effect and Its Ability to Improve the Resistance against Helicobacter pylori Infection.

Authors:  Valeria Garcia-Castillo; Guillermo Marcial; Leonardo Albarracín; Mikado Tomokiyo; Patricia Clua; Hideki Takahashi; Haruki Kitazawa; Apolinaria Garcia-Cancino; Julio Villena
Journal:  Microorganisms       Date:  2020-03-27

6.  Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by Helicobacter pylori and Its Effect on Gastrointestinal Flora.

Authors:  Guigen Teng; Yun Liu; Ting Wu; Weihong Wang; Huahong Wang; Fulian Hu
Journal:  Biomed Res Int       Date:  2020-08-31       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.